What we found on the web about Sanofi-Aventis
Sanofi-Aventis - Wikipedia, the free encyclopedia
Sanofi-Aventis (Euronext: SAN, NYSE: SNY), headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales.
Insulin glargine - Wikipedia, the free encyclopedia
Insulin glargine, marketed by Sanofi-Aventis under the name Lantus, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with ...
Sanofi-aventis ANZ
sanofi-aventis pharmaceutical research, development, careers and product information for pharmaceuticals, cardiovascular diseases, bone diseases, oncology, central nervous system ...
Sanofi-aventis - Kosmix : Reference, Videos, Images, News, Shopping ...
Mon Nov 16, 2009 09:21 AM PST. PRESSEMITTEILUNGEN - Sanofi-aventis Launches Major New Registry ... Sanofi-aventis Launches Major New Registry Including Over 10000 Patients ...
sanofi-aventis Outlook Web Access
This page is secured by RSA ACE/Server. To gain access to the protected system, you must enter your Windows domain user credentials and your SecurID passcode.
Sanofi-Aventis Inc. Customer Support
sanofi-aventis US LLC Customer Services Homepage ... We value flexibility, innovation, teamwork, and continuous improvement. We also take pride in our customer focus by ...
Sanofi-Aventis - SourceWatch
Sanofi-Aventis, based in France, is Europe's largest pharmaceutical company. The name comes from the 2004 merger of two French drug companies, Sanofi-Synthelabo and Aventis.
SNY: Summary for SANOFI-AVENTIS SA- Yahoo! Finance
Get detailed information on SANOFI-AVENTIS SA (SNY) including quote performance, Real-Time ECN, technical chart analysis, key stats, insider transactions, and the latest company ...
Entry added by Creative Administrator
Creative Administrator also edited:
Here is what users have to say about Sanofi-Aventis

Sanofi-Aventis ( , NYSE: SNY), headquartered in Paris, France, is a multinational pharmaceutical company, the world's fourth-largest by prescription sales. Sanofi-Aventis engages in the research and development, manufacturing and marketing of pharmaceutical products for sale principally in the prescription market, but the firm also develops over-the-counter medication. Sanofi-Aventis covers 7 major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur). The company is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA).

Welcome to CWAnswers

CWAnswers is your guide to the sprawling world wide web. The directory aims to provide a useful guide made by users. You can share your knowledge as well - simply register and edit your first entry. For questions just contact the team at support - at - cwanswers.com.

Weblinks

Top 10

Things you find nowhere else.

Comments

You must be logged in to post a comment.

No comments yet on this topic. Be the first one!
These recent articles mention Sanofi-Aventis
European, U.S. Stock-Index Futures Advance; Asian Shares Rise
Bloomberg
Bayer AG, Novartis AG and Sanofi-Aventis SA may climb after Deutsche Bank AG advised investors to buy the shares. Futures on the Dow Jones Euro Stoxx 50 Index, a benchmark for the euro region, added 1.1 percent at 7:23 a.m. in London.
Sanofi to fight globalisation, focus on new markets
The Guardian
LONDON, Nov 17 (Reuters) - French drugmaker Sanofi-Aventis sees major growth drivers in China and India but its chief executive says he will fight the kind of globalisation that stifles innovation and ignores local patients. Chris Viebacher...